A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
In a report released today, Gena Wang from Barclays maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price ...
In a report released today, William Pickering from Bernstein maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 10:30 AM ETCompany ParticipantsDr.
If you're an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech stock ...
Seven months after hiring a Peraton exec as its CEO, a Reston government contractor has added the former head of Peraton's ...
Users can converse with the AI assistant and get answers to questions like “Could you guide me to the nearest fine-dining ...
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...
The navigation system can retain an interaction in its memory and recall the dialogue so users can continue conversations and reference information throughout the drive.
The FDA is set to consider approval of an alternative to opioids developed by Vertex Pharmaceuticals, The Washington Post reported Jan. 13.
Everseen and Google Cloud are partnering on a Vision AI offering for retail stores. The companies will combine Everseen's ...
Google and Mercedes are teaming up to integrate the former's Gemini AI with the latter's in-car navigation system and ...